secwatch / observer
8-K filed December 31, 2024, 6:59 PM ET ticker AWHL CIK 0000926617
regulatory confidence high sentiment negative materiality 0.85

Aspira Women's Health Inc. (AWHL): Nasdaq/NYSE listing notice — Aspira Women's Health receives Nasdaq delisting notice for MVLS non-compliance

Aspira Women's Health Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 1.0

Aspira Women's Health Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
market value
Rules
5550(b)(2), 5810(c)(3)(C)
Exact text from the filing
December 31, 2024, the Company received written notice from the Staff of Nasdaq notifying it that the Company failed to regain compliance with the MVLS Requirement by the Compliance Date. As such, unless the Company requests an appeal of Nasdaq’s determination to delist the Company’s common stock from The Nasdaq Capital Market by January 7, 2025 and pays Nasdaq a hearing fee of $20,000, the Company’s common stock will be delisted from The Nasdaq Capital Market at the opening of business on January 10, 2025. While the Company intends to appeal Nasdaq’s decision, no guarantee can be provided tha
View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR
accession 0001493152-24-052755
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.